In October 2016 Mylan N.V. announced that its subsidiary, Mylan Inc., agreed to pay a $465 million settlement to the U.S. Department of Justice (DOJ) to resolve questions surrounding the classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector (EpiPen) for the Medicaid Drug Rebate Program.
RFID technology in hospitals is far from ubiquitous. However, more and more facilities are adopting RFID technology in a variety of areas.
With the uncertainty surrounding the 2016 presidential campaign, and continual concern about the U.S. economy, many of our most-popular stories this year debated the job market for pharmacists.
Arizona has become the latest state to limit opioid prescriptions-a trend that has some healthcare providers and experts concerned.
Last month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Comorbid CVD is an independent risk factor for CAP in patients with COPD. And inhaled steroids may increase CAP risk.
Use inhaled corticosteroids sparingly and only in these circumstances in patients with COPD. Details here.
The Illinois Department on Aging has begun sending pharmacist-led healthcare teams on home visits to seniors.
A team of researchers in Singapore set out to create a quality assessment tool that can be used to evaluate mobile apps that target medication-related problems.
For true networking to occur one has to give of oneself, and maybe not so ready to be on the take.
Pharmacists are ideally suited to help educate patients with diabetes and to raise their awareness of how risk factors for CV disease can be controlled.
As community pharmacies strive to play a greater role in population health management, could TB testing be an important item on the service menu?
When pharmacists get involved in patient care, significant improvements are often seen. Diabetes management is one of the most notable examples.
Drug Topics Executive Editor Anthony Vecchione sat down with NCPA CEO Douglas Hoey to discuss the current state of independent community pharmacy and some of the pressing issues facing the profession.
FDA approved ixazomib (Ninlaro, Takeda) in combination with lenalidomide and dexamethasone
Pharmacy-led interventions in prior authorization processing resulted in a statistically significant benefit in improving time to PA approval, time to first fill, and time too pick-up.
A majority of pharmacists don’t talk to patients about online pharmacies.
On July 20, 1992, a Drug Topics cover story posed the question, “Is Mail Order bombing?”
In 2015, the number of independent pharmacies declined along with prescription volume.
I missed that Dietary Supplement Bus in 1994-- and so did the pharmacy profession.
While many aspects of diabetes care are universal, patients with type I diabetes (T1D) often face a unique set of obstacles and challenges.
Stress remains a pressing issue, but most community pharmacists are satisfied with compensation and working conditions.
The U.S. Department of Justice charged 16 individuals in Florida federal court as part of an elaborate fraud scheme that allegedly used call centers and kickbacks to generate bogus prescriptions and bilk government and private insurers for $175 million.
FDA approved EpclusaTM (sofosbuvir and velpatasvir, (SOF-VEL) for adults with chronic hepatitis C infection both with compensated cirrhosis or without cirrhosis as well as in combination with ribavirin for hepatitis C with decompensated cirrhosis.
Despite evidence that optimal glycemic control can help reduce disease progression and complications, most patients do not achieve recommended treatment goals.
A randomized controlled study has found that oral syringes are more accurate than dosing cups when parents measure doses of liquid medications for their children.
While the number of painkiller Rxs is soaring elsewhere, Wisconsin is celebrating a reduction.
Pharmacists’ involvement in cardiovascular risk screening resulted in referrals to physicians for patients who were under-diagnosed.
Medicare Part D recipients are most concerned about prescription drug costs-and their co-pay costs are the most important factor when choosing a pharmacy.
Researchers found that estimated coverage for RV at 19 to 35 months of age lags behind the other vaccines recommended at ages two, four, and six.